NCT03128151

Brief Summary

The NMB (Neuromuscular Blockade) is the most frequent complication in anesthesiology associated with an increase in adverse respiratory events in the postoperative period. Its appearance depends on multiple factors. The introduction of a comprehensive educational strategy aimed at promoting the proper management of NMB in the intraoperative period and a package of measures that must be performed (intraoperative neuromuscular monitoring and reversal of the effect of neuromuscular blockers) may contribute to a decrease in the incidence of NMB, Increase safety in the surgical patient and decrease associated costs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,314

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 25, 2017

Completed
1.2 years until next milestone

Study Start

First participant enrolled

June 20, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

April 10, 2017

Last Update Submit

September 21, 2023

Conditions

Keywords

NMB (Neuromuscular Blockade)AnesthesiaCurarizationTOFr (train of four)PACU (postanesthesia care unit)Monitorization

Outcome Measures

Primary Outcomes (1)

  • Incidence of PORC.

    To reduce the incidence of PORC ≤ 10% by the introduction of an educational program and a bundle of preventive measures (including intraoperative monitoring and reversal of neuromuscular blocking agents (NMBA)).

    Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.

Secondary Outcomes (5)

  • Compliance rate with the bundle of measures

    Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.

  • Rate of intraoperative monitoring

    Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).

  • Rate of reversal of NMBA

    Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).

  • Perception of safety -increase- by anesthesiologists

    Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).

  • Incidence of postoperative adverse events.

    Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).

Study Arms (2)

Study group

Intraoperative neuromuscular monitoring and pharmacological reversion according to data sheet

Behavioral: Educational program for clinicians: implementation of a package of clinical prevention measures of NMB

Control group

Treated according to usual clinical practice

Interventions

Intraoperative neuromuscular monitoring and pharmacological reversion of NMB according to data sheet

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients submitted to general anesthesia with neuromuscular blockade, extubated before admission to the Post Anesthesia Recovery Unit

You may qualify if:

  • Patients older than 18 years.
  • Classification of the American Society of Anesthesiologists (ASA I-III).
  • Patients with absence of cognitive deficit.
  • Informed informed consent prior to surgery

You may not qualify if:

  • Negative of the patient to participate in the study
  • Patients under the age of 18 or incapable of giving their consent
  • ASA IV-V
  • Pregnancy or breastfeeding
  • Associated neuromuscular disorders
  • Diabetes mellitus with diagnosed neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital la Fe

Valencia, 46026, Spain

Location

Related Publications (1)

  • Diaz-Cambronero O, Mazzinari G, Errando CL, Garutti I, Gurumeta AA, Serrano AB, Esteve N, Montanes MV, Neto AS, Hollmann MW, Schultz MJ, Argente Navarro MP; Reducing the Incidence of Post Operative Residual Curarization Zero investigators. An educational intervention to reduce the incidence of postoperative residual curarisation: a cluster randomised crossover trial in patients undergoing general anaesthesia. Br J Anaesth. 2023 Sep;131(3):482-490. doi: 10.1016/j.bja.2023.02.031. Epub 2023 Apr 20.

Study Officials

  • Oscar Diaz Cambronero, MD

    Hospital La Fe

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physician, specialist in Anesthesiology

Study Record Dates

First Submitted

April 10, 2017

First Posted

April 25, 2017

Study Start

June 20, 2018

Primary Completion

December 30, 2018

Study Completion

December 31, 2018

Last Updated

September 22, 2023

Record last verified: 2023-09

Locations